CII Elects Rajiv Memani As New President For 2025-26

CII Elects Rajiv Memani As New President For 2025-26

New Delhi: The Confederation of Indian Trade (CII) on Sunday elected new workplace bearers for the 12 months 2025-26 and Rajiv Memani, Chairman and CEO of EY India, has assumed workplace because the CII President. He takes over from Sanjiv Puri, Chairman and Managing Director of ITC Ltd, the apex trade chamber stated in an announcement.

Memani can also be a member of EY World Government Board because the Chair of its Development Markets Council. He’s a trusted advisor to giant Indian corporations, personal fairness funds and multinational organisations, principally advising them on constructing confidence, mergers and acquisitions, expertise and sensible capital allocation methods.

In his Rising Markets (EM) function, his duties embrace advancing EY’s rising markets progress agenda and connecting their priorities with the worldwide agency’s investments.

Previous to turning into the Chairman and CEO, Memani established EY India’s market-leading Company Finance (now Technique & Transactions) apply within the late 90s. He was additionally the President-Designate of the Confederation of Indian Trade for the 12 months 2024-25 and Vice President for the 12 months 2023-24.

R Mukundan, Managing Director and CEO of Tata Chemical compounds Restricted takes over as CII’s President-Designate for 2025-26, stated the apex enterprise chamber. Mukundan joined Tata Administrative Service in 1990, after completion of MBA from FMS, Delhi College. He’s a distinguished alumnus of IIT, Roorkee; Fellow of Indian Chemical Society and an alumnus of Harvard Enterprise College.

Dr Suchitra Ok Ella, Co-founder and Managing Director, Bharat Biotech Worldwide Restricted takes over as CII Vice President for 2025-26. She was instrumental in founding Bharat Biotech method again in 1996.

Previously decade, Dr (Mrs) Ella has co-founded and nurtured a number of corporations in veterinary sciences, agri-biotech parks, meals processing together with pre-clinical toxicology and analysis institute, in accordance with the CII assertion.

Leave a Reply

Your email address will not be published. Required fields are marked *